Hypoxia as a target for drug combination therapy of liver cancer

Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer deaths worldwide. The standard of care for intermediate HCC is transarterial chemoembolization, which combines tumour embolization with locoregional delivery of the chemotherapeutic doxorubicin. Embolization therapies induce h...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowyer, Cressida, Lewis, Andrew L., Lloyd, Andrew W., Phillips, Gary J., Macfarlane, Wendy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Preclinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515631/
https://www.ncbi.nlm.nih.gov/pubmed/28542038
http://dx.doi.org/10.1097/CAD.0000000000000516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515631/
https://www.ncbi.nlm.nih.gov/pubmed/28542038
http://dx.doi.org/10.1097/CAD.0000000000000516

Ejemplares similares